Viewing Study NCT02808650


Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2025-12-29 @ 10:55 AM
Study NCT ID: NCT02808650
Status: COMPLETED
Last Update Posted: 2023-12-20
First Post: 2016-06-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Sponsor: Children's Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Childhood Solid Neoplasm View
None Recurrent Malignant Solid Neoplasm View
None Recurrent Primary Central Nervous System Neoplasm View
None Refractory Malignant Solid Neoplasm View
None Refractory Primary Central Nervous System Neoplasm View
Keywords: